Document is current
Any future updates will be listed below
-
Authors
Puy, Laurent
Mazzoleni, Valentina
Samarasekera, Neshika
Morotti, Andrea
Tsai, Hsin-Hsi
Gaberel, Thomas
Cordonnier, Charlotte
Bérézowski, Vincent
- License Information
-
More Information
Article History
Received: 14 May 2025
Revised: 14 August 2025
Accepted: 26 September 2025
First Online: 11 October 2025
Declarations
:
: Disclosures: V.M, N.S, HH.T and T.G : none A.M declares the following type of interests: consulting fees from EMC-REG International and AstraZeneca L.P declares the following type of interests: speaker fees (Novonordisk) C.C has received grant funding from the French Ministry of Health, the French National Research Agency as part of the future investment program integrated into France 2030, under grant agreement No. ANR-23-RHUS-06 (RHU TIPITCH), and consulting services with Bayer. She also reports membership of several data and safety monitoring boards for clinical trials, and Associate Editor of the Stroke journal.Disclosures:V.M, N.S, HH.T and T.G : noneA.M declares the following type of interests: consulting fees from EMC-REG International and AstraZenecaL.P declares the following type of interests: speaker fees (Novonordisk)C.C has received grant funding from the French Ministry of Health, the French National Research Agency as part of the future investment program integrated into France 2030, under grant agreement No. ANR-23-RHUS-06 (RHU TIPITCH), and consulting services with Bayer.She also reports membership of several data and safety monitoring boards for clinical trials, and Associate Editor of the Stroke journal.
